HIPS researchers are opening up new avenues for the treatment of multi-resistant pathogens Antibiotics are a double-edged sword – they should be as toxic as possible to pathogenic bacteria while being ...
The new molecules target a metabolic pathway that only occurs in bacterial cells, thus sparing human cells. The team published its results in the journal Angewandte Chemie International Edition.